Australian authorities recently amended legislation to allow commercial rock lobster fishers to sell large quantities from the back of their boats during December and January after China imposed a near-total import ban.
So far the Australian public has responded enthusiastically, offering a much-needed lifeline to Camarda and his fellow vendors.
On a pre-Christmas weekday, the world-renowned western rock lobster was sold directly on the quay for $34 a kilogram — a 36 percent markdown.
But demand across Australia is high that some supermarkets placed limits on the number of lobsters customers can buy.
Australia’s rock lobster exports were worth half a billion US dollars annually, with 94 percent usually going to China.
But a few weeks ago, China imposed a near-total import ban on lobster as part of a politically charged “shadow trade war.”
China has been raising a list of issues including Australia’s call for an inquiry into the COVID-19 origins, and a ban of Huawei’s in the nation’s 5G network.
So far, the Australian economy has returned to growth in the last quarter, exiting a COVID-induced recession.
But individual businesses have been forced to find new customers as a dozen Australian sectors hit with import levies, with the barley industry particularly badly hit. Exporters stand to lose as much as $2-4 billion worth of sales.
Some barley farmers have planted other grains or re-routed shipments to the Middle East.
Before the COVID-19 pandemic, prices topped $80 a kg in Western Australia and usually averaged around $53 per kilo.


Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 



